COVID-19: Russian Research Center Says Early Trials Of Its Coronavirus Vaccine Successful
Russia Russia’s Vektor, a secret state virology research center in Siberia, says early clinical trials of its coronavirus vaccine have proven successful. “The first two phases of clinical trials demonstrated the effectiveness and safety of the EpiVacCorona vaccine,” Vektor’s press...